11/18/2026
Palliser Capital Pushes for Chemring Break-Up
Financial Times (11/18/26) Levingston, Ivan; Pfeifer, Sylvia
A hedge fund that has built a stake in FTSE 250 group Chemring (LSE: CHG) is calling for a break-up of the British defense company, arguing it has failed to capitalize on a surge in European military budgets. Palliser Capital, a London-based investment group led by former Elliott Management senior executive James Smith, has urged the Chemring board to consider a strategic review and possible sale of its electronic warfare business Roke. Such a separation would allow Chemring to focus on expanding its more attractive “energetics” division, which specializes in explosives and countermeasures, such as flares and decoys to protect from attacks, Palliser said in a letter to Chemring on Wednesday seen by the FT. Chemring was the “only independent, publicly listed supplier of high-end military explosives on the continent,” the letter said. The company had the chance “to capitalize on the most significant growth period in its more than 120-year history,” it added, but the “scale of this opportunity has not been matched by the ambition of Chemring’s strategy.” “Over the course of the largest global rearmament cycle since the second world war, Chemring has delivered the weakest shareholder returns of any company in its peer group due to a total lack of earnings growth,” the letter from Palliser said. Roke, a defense engineering business, should be sold off to a trade buyer and could be valued at roughly £600 million to £730 million on its own, it said. Chemring’s market value is about £1.4 billion and its shares have been roughly flat over the past year. Palliser has about a 3% stake in Chemring and asked in the letter to meet with the company's chair, Tony Wood. The investment firm has previously held discussions with Chemring management, people familiar with the matter said. The break-up proposal comes amid impending changes to Chemring's senior leadership, with chief executive Michael Ord due to retire in January after more than eight years at the helm. His successor, Tom Newman, who was formerly at Babcock International (LSE: BAB), joined the group in October. Chemring is among the UK's most prominent publicly listed defense groups, supplying materials and components for missile systems and explosives. It has benefited from increased military spending in the wake of the conflict in Ukraine, reporting a record order book of £1.4 billion for the financial year to the end of October. It announced plans to sell its U.S. sensors business earlier this month. However, it has suffered from temporary delays in contract awards in its UK sensors business, with underlying operating profits falling 8% to £24.5 million for the six months to the end of April. Private equity group Albion River has built a 14% stake to become Chemring's largest shareholder. Palliser has previously launched campaigns, including at the UK’s Capricorn Energy (LON: CNE), where it pushed for change to the company’s board in moves that ultimately led to an agreed sale of the company. Chemring said it welcomed engagement with its shareholders, but did not comment on media or market speculation.
Read the article